Ben Enejo is a Principal at Arthur D. Little (ADL), based in London, and a member of ADL’s global Healthcare & Life Sciences practice. Mr. Enejo is an experienced life science management consultant and has worked with various global pharmaceutical companies on business transformation initiatives. He has managed complex programs, including pharma development, new service introduction, quality and compliance process improvement, new product launch planning, market-entry strategy, business acquisition, due diligence, drug safety and pharmacovigilance (PV) transformation, and global business services. Mr. Enejo also focuses on supporting clients in navigating and implementing the new EU clinical trial regulations. He holds an MBA with qualifications in molecular medicine, pharmacology and physiology, and program management. Mr. Enejo can be reached at firstname.lastname@example.org.